Jacob J. Orme

1.3k total citations · 1 hit paper
74 papers, 744 citations indexed

About

Jacob J. Orme is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Jacob J. Orme has authored 74 papers receiving a total of 744 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Pulmonary and Respiratory Medicine, 31 papers in Oncology and 25 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Jacob J. Orme's work include Prostate Cancer Treatment and Research (28 papers), Radiopharmaceutical Chemistry and Applications (18 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Jacob J. Orme is often cited by papers focused on Prostate Cancer Treatment and Research (28 papers), Radiopharmaceutical Chemistry and Applications (18 papers) and Cancer Immunotherapy and Biomarkers (14 papers). Jacob J. Orme collaborates with scholars based in United States, Austria and China. Jacob J. Orme's co-authors include Chandra Mohan, Daniel S. Childs, Haidong Dong, Fabrice Lucien, Haojie Huang, Aaron S. Mansfield, Geoffrey B. Johnson, Roxana Dronca, Sean S. Park and Yong Du and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jacob J. Orme

57 papers receiving 732 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Theranostics and artificial intelligence: new frontiers in personalized medicine

2024 52 citations Gokce Belge Bilgin, Brian J. Burkett et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jacob J. Orme United States	14	251	241	227	201	112	74	744
Takafumi Koyama Japan	19	136 0.5×	293 1.2×	447 2.0×	168 0.8×	144 1.3×	87	871
Ilaria Marech Italy	18	427 1.7×	441 1.8×	291 1.3×	192 1.0×	94 0.8×	39	932
Satoshi Muto Japan	18	229 0.9×	246 1.0×	406 1.8×	311 1.5×	223 2.0×	72	898
Jane Ruppel United States	13	221 0.9×	162 0.7×	224 1.0×	145 0.7×	49 0.4×	19	633
Naoyuki Okabe Japan	15	173 0.7×	212 0.9×	392 1.7×	255 1.3×	197 1.8×	56	706
Christina Williamson United States	13	208 0.8×	534 2.2×	189 0.8×	193 1.0×	122 1.1×	25	979
Andrea Milani Italy	12	109 0.4×	268 1.1×	416 1.8×	208 1.0×	123 1.1×	35	765
Sophia Frentzas Australia	14	121 0.5×	276 1.1×	388 1.7×	152 0.8×	112 1.0×	65	737
Eustachio Ruggieri Italy	13	122 0.5×	237 1.0×	210 0.9×	121 0.6×	89 0.8×	19	590
Yu‐Nien Sun United States	13	92 0.4×	298 1.2×	206 0.9×	129 0.6×	120 1.1×	30	702

Countries citing papers authored by Jacob J. Orme

Since Specialization

Citations

This map shows the geographic impact of Jacob J. Orme's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob J. Orme with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob J. Orme more than expected).

Fields of papers citing papers by Jacob J. Orme

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob J. Orme. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob J. Orme. The network helps show where Jacob J. Orme may publish in the future.

Co-authorship network of co-authors of Jacob J. Orme

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob J. Orme. A scholar is included among the top collaborators of Jacob J. Orme based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob J. Orme. Jacob J. Orme is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jatoi, Aminah, Kathryn J. Ruddy, Jacob J. Orme, et al.. (2025). Olanzapine for Managing Side Effects From Antiangiogenic Tyrosine-Kinase Inhibitors. Journal of Pain and Symptom Management. 70(2). 182–188.

Zarka, Jonathan, Irbaz Bin Riaz, Syed Arsalan Ahmed Naqvi, et al.. (2025). 2403P LuRa: Efficacy and Tolerability of Radium-223 Following [177Lu]Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer. Annals of Oncology. 36. S1223–S1223.

Naqvi, Syed Arsalan Ahmed, Jack R. Andrews, Alan H. Bryce, et al.. (2025). Automated risk stratification in localized prostate cancer using an AI-assisted framework.. Journal of Clinical Oncology. 43(5_suppl). 341–341.

Andrews, Jack R., Aurélie De Bruycker, Ryan Phillips, et al.. (2025). PSMA+ Extracellular Vesicles Are a Biomarker for SABR in Oligorecurrent Prostate Cancer: Analysis from the STOMP-like and ORIOLE Trial Cohorts. Clinical Cancer Research. 31(6). 1142–1149. 5 indexed citations

Bilgin, Gokce Belge, Fabrice Lucien, Aadel A. Chaudhuri, et al.. (2025). Current and future directions in theranostics for neuroendocrine prostate cancer. Cancer Treatment Reviews. 136. 102941–102941. 4 indexed citations

Ahmed, Mohamed E., Ahmed Mahmoud, Irbaz Bin Riaz, et al.. (2024). Survival Patterns Based on First-site–specific Visceral Metastatic Prostate Cancer: Are Outcomes of Visceral Metastases the Same?. European Urology Open Science. 66. 38–45. 3 indexed citations

Bilgin, Gokce Belge, Brian J. Burkett, Cem Bilgin, et al.. (2024). Neurologic Symptoms After¹⁷⁷Lu-Prostate-Specific-Membrane Antigen-617 Therapy: A Single-Center Experience. Journal of Nuclear Medicine. 65(9). 1402–1408.

Mahmoud, Ahmed, Mohamed E. Ahmed, Spyridon P. Basourakos, et al.. (2024). Prostate Cancer Lung Metastasis: Clinical Insights and Therapeutic Strategies. Cancers. 16(11). 2080–2080. 2 indexed citations

Mahmoud, Ahmed, Mohamed E. Ahmed, A. Tuba Kendi, et al.. (2023). Low PSA radiographic disease progression on C11‐choline PET. SHILAP Revista de lepidopterología. 5(2). 319–324. 1 indexed citations

10.

Mahmoud, Ahmed, Robert W. Gao, Mohamed E. Ahmed, et al.. (2023). Metastasis-Directed Therapy for Metachronous Lung Metastases in Prostate Cancer. JU Open Plus. 1(10). 2 indexed citations

11.

Mahmoud, Ahmed, Daniel S. Childs, Mohamed E. Ahmed, et al.. (2023). Treatment modalities and survival outcomes in prostate cancer parenchymal brain metastasis. The Prostate. 84(3). 237–244. 2 indexed citations

12.

Mahmoud, Ahmed, Rodrigo Rodrigues Pessoa, I. D. Garg, et al.. (2023). Antibody-Based Therapeutics for the Treatment of Renal Cell Carcinoma: Challenges and Opportunities. The Oncologist. 28(4). 297–308. 4 indexed citations

13.

Li, Xiang, Bo Tang, Hao Li, et al.. (2023). SETDB1 Modulates Degradation of Phosphorylated RB and Anticancer Efficacy of CDK4/6 Inhibitors. Cancer Research. 83(6). 875–889. 23 indexed citations

14.

Novotny, Paul J., Elizabeth Cathcart-Rake, Jacob J. Orme, et al.. (2023). An evaluation of the effect of lithium on taxane-induced neuropathy. Supportive Care in Cancer. 31(5). 299–299. 2 indexed citations

15.

Orme, Jacob J., Lance C. Pagliaro, J. Fernando Quevedo, Sean S. Park, & Brian A. Costello. (2022). Rational Second-Generation Antiandrogen Use in Prostate Cancer. The Oncologist. 27(2). 110–124. 12 indexed citations

16.

Childs, Daniel S., Lindsey R. Sangaralingham, Jacob J. Orme, et al.. (2022). Slow Uptake of an Effective Therapy: Patterns of Olanzapine Prescribing for Those Receiving Highly Emetogenic Chemotherapy. JCO Oncology Practice. 18(12). e1953–e1960. 3 indexed citations

17.

Lucien, Fabrice, Jing Qian, Jacob J. Orme, et al.. (2022). Tumor-Derived Extracellular Vesicles Predict Clinical Outcomes in Oligometastatic Prostate Cancer and Suppress Antitumor Immunity. International Journal of Radiation Oncology*Biology*Physics. 114(4). 725–737. 13 indexed citations

18.

Foster, Nathan R., Fabrice Lucien, Svetomir N. Markovic, et al.. (2022). Rescuing Cancer Immunity by Plasma Exchange in Metastatic Melanoma (ReCIPE-M1): protocol for a single-institution, open-label safety trial of plasma exchange to clear sPD-L1 for immunotherapy. BMJ Open. 12(5). e050112–e050112. 10 indexed citations

19.

Shi, Lei, Yuqian Yan, Yundong He, et al.. (2021). Mutated SPOP E3 Ligase Promotes 17βHSD4 Protein Degradation to Drive Androgenesis and Prostate Cancer Progression. Cancer Research. 81(13). 3593–3606. 25 indexed citations

20.

Orme, Jacob J., Yong Du, Kamala Vanarsa, et al.. (2016). Heightened cleavage of Axl receptor tyrosine kinase by ADAM metalloproteases may contribute to disease pathogenesis in SLE. Clinical Immunology. 169. 58–68. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact